Nomura Holdings
NVCR icon

Nomura Holdings’s NovoCure NVCR Stock Holding History

Nomura Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,137
Closed -$386K – 2283
2021
Q4 		$386K Sell
5,137
-10,214
-67% -$1.03M ﹤0.01% 1610
2021
Q3 		$1.78M Buy
15,351
+8,979
+141% +$1.36M ﹤0.01% 956
2021
Q2 		$1.42M Sell
6,372
-9,450
-60% -$1.84M ﹤0.01% 979
2021
Q1 		$2.09M Buy
15,822
+10,922
+223% +$1.73M ﹤0.01% 845
2020
Q4 		$849K Sell
4,900
-87,409
-95% -$12M ﹤0.01% 1089
2020
Q3 		$10.3M Buy
92,309
+83,867
+993% +$6.71M 0.02% 351
2020
Q2 		$499K Sell
8,442
-11,494
-58% -$756K ﹤0.01% 871
2020
Q1 		$1.34M Buy
+19,936
New +$1.58M 0.01% 534

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nomura Holdings's NVCR Position: Q1 2022 in Review

Nomura Holdings sold out of NovoCure (NVCR) in Q1 2022, closing a stake of 5,137 shares — an estimated $386K sold.

Nomura Holdings first reported a position in NVCR in Q1 2020 and held it in 8 quarters. The position peaked at $10.3M in Q3 2020. 308 funds tracked by Wall St. Rank hold NVCR as of Q1 2022.

  • Nomura Holdings reported no remaining NovoCure position as of Q1 2022 after selling out during the quarter.
  • Nomura Holdings sold 5,137 NovoCure shares in Q1 2022, an estimated $386K.
  • Nomura Holdings first reported a position in NovoCure in Q1 2020 and held it in 8 quarters.
  • Nomura Holdings's NovoCure position peaked at $10.3M in Q3 2020.
  • 308 funds tracked by Wall St. Rank held NovoCure as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.